Basis: Four-quarter free cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The free cash flow yield is N/A as of 2026-10-06T18:22:58.816Z.
Calculation as of: 2026-10-06T18:22:58.816Z.
Quote observation: 2026-10-06T18:19:48.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 970d877bc7db717cbed859036c212f4e9de57f4ce891843b12d0c27006da4837
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
FREE CASH FLOW YIELD
N/A
Seaport Therapeutics, Inc. Common Stock
Market Cap
$942.38M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$938.35M
Free Cash Flow Yield
N/A
TTM Avg
16.58%
3Y Avg
16.62%
5Y Avg
16.62%
Market Cap
$930.32M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$969.98M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$912.83M
Free Cash Flow Yield
5.35%
TTM Avg
7.65%
3Y Avg
6.69%
5Y Avg
6.16%
Market Cap
$976.29M
Free Cash Flow Yield
18.39%
TTM Avg
13.64%
3Y Avg
14.16%
5Y Avg
10.28%
Market Cap
$899.69M
Free Cash Flow Yield
10.48%
TTM Avg
10.89%
3Y Avg
6.48%
5Y Avg
5.13%
| NAME | MARKET CAP | FREE CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Seaport Therapeutics, Inc. Common Stock (SPTX) | $942.38M | N/A | N/A | N/A | N/A |
| Kura Oncology, Inc. (KURA)vs › | $938.35M | N/A | 16.58% | 16.62% | 16.62% |
| CeriBell, Inc. (CBLL)vs › | $935.90M | N/A | N/A | N/A | N/A |
| MoonLake Immunotherapeutics (MLTX)vs › | $930.32M | N/A | N/A | N/A | N/A |
| Savara Inc. (SVRA)vs › | $953.94M | N/A | N/A | N/A | N/A |
| Aktis Oncology, Inc. (AKTS)vs › | $969.98M | N/A | N/A | N/A | N/A |
| HealthStream, Inc. (HSTM)vs › | $912.83M | 5.35% | 7.65% | 6.69% | 6.16% |
| Pacira BioSciences, Inc. (PCRX)vs › | $976.29M | 18.39% | 13.64% | 14.16% | 10.28% |
| Bioventus Inc. (BVS)vs › | $899.69M | 10.48% | 10.89% | 6.48% | 5.13% |
| LB Pharmaceuticals Inc Common Stock (LBRX)vs › | $987.62M | N/A | N/A | N/A | N/A |
FCF Yield
N/A
Earnings Yield
N/A
Dividend Yield
N/A
Formula: FCF Yield = (Free Cash Flow / Market Cap) × 100
How FCF Yield is used:
FCF vs earnings: Differences between FCF yield and earnings yield can reflect capital expenditures, working capital changes, and other non-cash accounting items.
FCF Yield measures free cash flow relative to market capitalization. It compares cash generation after capital expenditures with the equity value of the company.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
